WebDisclosure WebDisclosure
Basculer en Français
10603 Companies
225009 Keywords
153732 Articles
119071 Press releases
Headlines Articles Press releases Prolacta Bioscience Remove
  1. Home
  2. Companies
  3. Prolacta Bioscience
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/19/2026 at 08:10, 4 months 1 day ago

    Japan Approves Prolacta's Human Milk Fortifiers as Prescription Drug

    Neonatal Care Japan Approval Infant Nutrition Prolacta Human Milk-based
  • BRIEF

    published on 02/19/2026 at 08:10, 4 months 1 day ago

    Le Japon approuve les fortifiants de lait maternel de Prolacta comme médicament sur ordonnance

    Soins Néonatals Approbation Du Japon Nutrition Infantile Prolacta À Base De Lait Maternel
  • PRESS RELEASE

    published on 02/19/2026 at 08:05, 4 months 1 day ago

    A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

    Japan approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as Prescription Drug for Vulnerable Infants, supported by clinical evidence and regulatory milestones
    Japan Neonatal Care Prolacta Bioscience 100% Human Milk-Based Fortifiers Prescription Drug
    Logo of Prolacta Bioscience
Accesswire
  • Published on 06/20/2026 at 01:00, 17 hours 52 minutes ago

    Onco-Innovations Announces Non-Brokered LIFE Offering

  • Published on 06/20/2026 at 00:00, 18 hours 52 minutes ago

    Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

  • Published on 06/19/2026 at 04:30, 1 day 14 hours ago

    Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp

  • Published on 06/19/2026 at 01:20, 1 day 17 hours ago

    American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

  • Published on 06/19/2026 at 01:07, 1 day 17 hours ago

    Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE
EQS Group
  • Published on 06/20/2026 at 06:00, 12 hours 52 minutes ago

    Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong

  • Published on 06/19/2026 at 20:17, 22 hours 35 minutes ago

    2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations

  • Published on 06/19/2026 at 20:17, 22 hours 35 minutes ago

    2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité

  • Published on 06/19/2026 at 19:01, 23 hours 51 minutes ago

    Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

  • Published on 06/19/2026 at 18:29, 1 day ago

    Designated Person Notification

View all EQS
Les Echos
  • Published on 06/19/2026 at 19:33, 23 hours 19 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026

  • Published on 06/19/2026 at 19:33, 23 hours 19 minutes ago

    Disclosure of transactions in own shares from June 15 to June 19, 2026

  • Published on 06/19/2026 at 19:23, 23 hours 28 minutes ago

    Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

  • Published on 06/19/2026 at 19:23, 23 hours 28 minutes ago

    Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026

  • Published on 06/19/2026 at 19:05, 23 hours 47 minutes ago

    CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy